uniQure N.V. Basic Shares Outstanding (Weighted Average)
uniQure N.V. (QURE) reported Basic Shares Outstanding (Weighted Average) of 62.74 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-05
- uniQure N.V. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 62.74M shares, a 18.14% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 62.37M shares, a 27.63% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 58.52M shares, a 20.11% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 54.81M shares, a 12.72% increase year-over-year.
- uniQure N.V. weighted average number of shares outstanding, basic for fiscal 2025 was 57.50M shares, a 18.20% increase from fiscal 2024.
- uniQure N.V. weighted average number of shares outstanding, basic for fiscal 2024 was 48.65M shares, a 2.05% increase from fiscal 2023.
- uniQure N.V. weighted average number of shares outstanding, basic for fiscal 2023 was 47.67M shares, a 2.00% increase from fiscal 2022.
- uniQure N.V. weighted average number of shares outstanding, basic for fiscal 2022 was 46.74M shares, a 1.63% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | 62.74M shares 10-Q · filed 2026-05-05 | 62.56M shares derived: average of 2 quarters · filed 2026-05-05 | 61.21M shares derived: average of 3 quarters · filed 2026-05-05 | 59.61M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | 62.37M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 60.44M shares derived: average of 2 quarters · filed 2026-03-02 | 58.56M shares derived: average of 3 quarters · filed 2026-03-02 | 57.50M shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 58.52M shares 10-Q · filed 2025-11-10 | 56.66M shares derived: average of 2 quarters · filed 2025-11-10 | 55.88M shares 10-Q · filed 2025-11-10 | 53.83M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2025-06-30 | 54.81M shares 10-Q · filed 2025-07-29 | 54.54M shares 10-Q · filed 2025-07-29 | 52.26M shares derived: average of 3 quarters · filed 2026-05-05 | 51.38M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2025-03-31 | 53.11M shares 10-Q · filed 2026-05-05 | 50.99M shares derived: average of 2 quarters · filed 2026-05-05 | 50.23M shares derived: average of 3 quarters · filed 2026-05-05 | 49.83M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 48.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 48.79M shares derived: average of 2 quarters · filed 2026-03-02 | 48.74M shares derived: average of 3 quarters · filed 2026-03-02 | 48.65M shares 10-K · filed 2026-03-02 |
| 2024-09-30 | 48.72M shares 10-Q · filed 2025-11-10 | 48.67M shares derived: average of 2 quarters · filed 2025-11-10 | 48.58M shares 10-Q · filed 2025-11-10 | 48.39M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | 48.62M shares 10-Q · filed 2025-07-29 | 48.50M shares 10-Q · filed 2025-07-29 | 48.28M shares derived: average of 3 quarters · filed 2026-03-02 | 48.15M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | 48.38M shares 10-Q · filed 2025-05-09 | 48.10M shares derived: average of 2 quarters · filed 2026-03-02 | 47.99M shares derived: average of 3 quarters · filed 2026-03-02 | 47.91M shares derived: average of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | 47.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 47.80M shares derived: average of 2 quarters · filed 2026-03-02 | 47.75M shares derived: average of 3 quarters · filed 2026-03-02 | 47.67M shares 10-K · filed 2026-03-02 |
| 2023-09-30 | 47.77M shares 10-Q · filed 2024-11-05 | 47.71M shares derived: average of 2 quarters · filed 2024-11-05 | 47.62M shares 10-Q · filed 2024-11-05 | 47.44M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 47.65M shares 10-Q · filed 2024-08-01 | 47.54M shares 10-Q · filed 2024-08-01 | 47.33M shares derived: average of 3 quarters · filed 2025-02-27 | 47.19M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 47.44M shares 10-Q · filed 2024-05-07 | 47.17M shares derived: average of 2 quarters · filed 2025-02-27 | 47.04M shares derived: average of 3 quarters · filed 2025-02-27 | 46.94M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 46.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 46.84M shares derived: average of 2 quarters · filed 2025-02-27 | 46.78M shares derived: average of 3 quarters · filed 2025-02-27 | 46.74M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 46.77M shares 10-Q · filed 2023-11-07 | 46.72M shares derived: average of 2 quarters · filed 2023-11-07 | 46.68M shares 10-Q · filed 2023-11-07 | 46.58M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | 46.67M shares 10-Q · filed 2023-08-01 | 46.63M shares 10-Q · filed 2023-08-01 | 46.52M shares derived: average of 3 quarters · filed 2024-02-28 | 46.42M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | 46.60M shares 10-Q · filed 2023-05-09 | 46.44M shares derived: average of 2 quarters · filed 2024-02-28 | 46.34M shares derived: average of 3 quarters · filed 2024-02-28 | 46.27M shares derived: average of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | 46.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 46.22M shares derived: average of 2 quarters · filed 2024-02-28 | 46.16M shares derived: average of 3 quarters · filed 2024-02-28 | 45.99M shares 10-K · filed 2024-02-28 |
| 2021-09-30 | 46.15M shares 10-Q · filed 2022-11-02 | 46.10M shares derived: average of 2 quarters · filed 2022-11-02 | 45.89M shares 10-Q · filed 2022-11-02 | 45.60M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | 46.04M shares 10-Q · filed 2022-08-08 | 45.75M shares 10-Q · filed 2022-08-08 | 45.41M shares derived: average of 3 quarters · filed 2023-02-27 | 45.18M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | 45.47M shares 10-Q · filed 2022-05-02 | 45.10M shares derived: average of 2 quarters · filed 2023-02-27 | 44.89M shares derived: average of 3 quarters · filed 2023-02-27 | 44.76M shares derived: average of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | 44.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 44.60M shares derived: average of 2 quarters · filed 2023-02-27 | 44.53M shares derived: average of 3 quarters · filed 2023-02-27 | 44.47M shares 10-K · filed 2023-02-27 |
| 2020-09-30 | 44.47M shares 10-Q · filed 2021-10-25 | 44.43M shares derived: average of 2 quarters · filed 2021-10-25 | 44.38M shares 10-Q · filed 2021-10-25 | |
| 2020-06-30 | 44.39M shares 10-Q · filed 2021-07-26 | 44.33M shares 10-Q · filed 2021-07-26 | ||
| 2019-12-31 | 40.00M shares 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |